ReCode Therapeutics
Menlo Park, CA
Works in Cardiovascular · ENT · Genetic & rare · GI & liver · Respiratory
ReCode Therapeutics is a clinical trial sponsor based in Menlo Park, CA. It has 2 active clinical trials with 278 planned participants, across 5 therapeutic areas. Since 2021 it has completed 4 trials and stopped 0 early.
Trial track record · since 2021
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about ReCode Therapeutics
ReCode Therapeutics is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 278 planned participants, in Cardiovascular, ENT, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 4 trials and stopped 0 early.
ReCode Therapeutics is based in Menlo Park, CA. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ReCode Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-19.
Approve Suite is not affiliated with ReCode Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.